Annual Meeting 2014: Overall survival results of MM-003 after adjustment for crossover Charlotte Pawlyn, MD

Annual Meeting 2014: Overall survival results of MM-003 after adjustment for crossover Charlotte Pawlyn, MD

216 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Charlotte Pawlyn, MD Institute of Cancer Research Sutton, United Kingdom Pomalidomide plus low-dose dexamethasone (POM plus LoDEX) versus high-dose dexamethasone (HiDEX) for relapsed or refractory multiple myeloma (RRMM): Overall survival (OS) results of MM-003 after adjustment for crossover Visit our website at: http://www.myeloma.org
Up Next Autoplay